DAAM1 and ovarian cancer: Authors documented that inhibition of DAAM1 prevents Wnt/Fz activation of Rho signaling and summarized that miR-208-5p/DAAM1 axis may be a novel prognostic marker/clinical target in metastatic phenotype of ovarian cancer [219].